- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00326430
Residential Cognitive and Interpersonal Therapy for Social Phobia
Residential Cognitive Therapy Versus Residential Interpersonal Therapy for Social Phobia: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Social phobia typically leads to severe impairment in work and other social life, and - without treatment - it can persist for decades. Given its prevalence, severity, and chronicity, effective treatment methods are strongly needed. However, traditional psychological and pharmacological treatments have had statistically significant, but clinically limited effects (Taylor, 1996).
Based on an empirical analysis of the cognitive processes in social phobia, Clark and Wells (1995) have developed a new cognitive model. Cognitive therapy (CT) derived from this model has been found to be superior to a combination of fluoxetine and self-exposure (Clark et al., 2003).
Social phobic symptoms may be viewed as a result of more general interpersonal difficulties and interpersonal psychotherapy (IPT) can be a reasonable alternative for social phobia (Lipsitz & Markowitz, 1996). A clinical case series indicates that social phobic patients improve during interpersonal psychotherapy for social phobia (IPT-SP; Lipsitz et al., 1999.
Study Type
Enrollment
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Buskerud
-
Vikersund, Buskerud, Norway, N-3370
- Modum Bad
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- DSM-IV criteria for social phobia
- the patient consider social phobia as the main current problem
- willingness to suspend use of psychotropic medication, alcohol and other substances
- acceptance of random allocation
- ability to speak Norwegian
- age 18-65 years.
Exclusion Criteria:
- a history of recurrent major depression currently treated sucessfully with antidepressant medications
- has immediate need for additional treatment
- current psychotic disorder or substance abuse
- organic mental disorder
- previously treated with similar models
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Social Avoidance
|
Social Anxiety
|
Secondary Outcome Measures
Outcome Measure |
---|
Depression
|
General Anxiety
|
Interpersonal Problems
|
Personality Disorders
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Asle Hoffart, Dr Psychol, Modum Bad
- Principal Investigator: Finn-Magnus Borge, Cand Psychol, Modum Bad
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Phobia
-
San Diego State UniversityNational Institute of Mental Health (NIMH)CompletedSocial Anxiety Disorder | Social PhobiaUnited States
-
Umeå UniversityUppsala UniversityCompleted
-
Umeå UniversityCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedSocial PhobiaUnited States
-
University of MinnesotaAstraZenecaCompletedSocial PhobiaUnited States
-
VU University of AmsterdamCompletedSocial Anxiety Disorder | Social PhobiaNetherlands
-
McMaster UniversityHamilton Health Sciences Corporation; Janssen-Ortho Inc., CanadaTerminated
-
Pherin Pharmaceuticals, Inc.CompletedSocial Anxiety Disorder | Social PhobiaUnited States
-
Umeå UniversityCompleted
Clinical Trials on Cognitive Therapy, Interpersonal Therapy
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
-
Vanderbilt UniversityCompletedDepressive SymptomsUnited States
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedMajor DepressionCanada
-
Linkoeping UniversityVästernorrland County Council, Sweden; REHSAM; Psychiatric clinic, Hospital of...UnknownShort Term Therapy for Outpatients Diagnosed With Major Depressive DisorderSweden
-
University of PittsburghCarnegie Mellon UniversityCompletedMajor Depressive DisorderUnited States
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Chief Scientist Office of the Scottish GovernmentCompletedMania | Bipolar Affective Disorder | HypomaniaUnited Kingdom
-
University of California, BerkeleyCompletedEveningness/SleepUnited States
-
Penn State UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedDepression | Major Depressive DisorderCanada